Status:
COMPLETED
Pulmonary Hypertension in Interstitial Lung Disease
Lead Sponsor:
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires
Collaborating Sponsors:
Hospices Civils de Lyon
Conditions:
Pulmonary Arterial Hypertension
Diffuse Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
HYPID study is an observational and prospective study of patients with interstitial lung disease and pre capillary hypertension diagnosed by right heart sided catheterization. The primary aim of the s...
Detailed Description
Pre capillary pulmonary hypertension (PH) may be present in patients with diffuse interstitial lung disease. In this context, PH represents an important factor of morbidity and mortality for these pa...
Eligibility Criteria
Inclusion
- pre capillary pulmonary hypertension at right heart sided catheterization with: mPAP \> or = 25 mmHg,PCWP \< or = 15 mmHg
- interstitial lung disease with diffuse infiltrative opacities on chest CT scan
Exclusion
- pulmonary hypertension related to a thromboembolic disease
- respiratory disease other than diffuse interstitial lung disease
- any etiological factor of pulmonary arterial hypertension based on DANA POINT classification other than diffuse interstitial lung disease
- any progressive disease associated to a life expectancy less than 6 months other than pulmonary hypertension, diffuse interstitial lung disease and respiratory insufficiency
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT01443598
Start Date
July 1 2010
End Date
June 1 2016
Last Update
June 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Louis Pradel Hospital (Bâtiment A4)
Lyon, Bron, France, 69677